Discontinued — last reported Q4 '21
Business Segments · Goodwill, Impairment Loss
Proprietary Products — Goodwill, Impairment Loss
West Pharmaceutical Services Proprietary Products — Goodwill, Impairment Loss remained flat by 0.0% to $25.00K in Q4 2021 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2021
Rolls up toGoodwill impairment
How to read this metric
High impairment losses signal that past acquisitions are failing to meet performance expectations.
Detailed definition
This represents the specific charge taken when the carrying value of goodwill associated with the Proprietary Products s...
Peer comparison
Standard 'Goodwill Impairment' charge found in the notes to consolidated financial statements.
Metric ID:
wst_segment_proprietary_products_goodwill_impairment_lossHistorical Data
1 years
| FY'21 | |
|---|---|
| Value | $100.00K |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's proprietary products — goodwill, impairment loss?
- West Pharmaceutical Services (WST) reported proprietary products — goodwill, impairment loss of $25.00K in Q4 2021.
- What does proprietary products — goodwill, impairment loss mean?
- A write-down of the value of previously acquired businesses due to lower-than-expected performance.